UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November  22, 2010
 
Commission File No. 333-136643
 
ONE BIO, CORP.  
(Exact name of registrant as specified in its charter)
 
Florida
59-3656663
(State or other jurisdiction of
(IRS Employer Identification No.)
incorporation or organization)
 
 
19950 West Country Club Drive, Suite 100, Aventura, FL 33180
 (Address of principal executive offices)

305-328-8662  
 
(Registrant's telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
 


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 8.01      Other Events
 
On November 22, 2010, ONE Bio, Corp. (the “Company”) entered into an agreement with Michael Weingarten, its Chairman of the Board and ONE-V Group, LLC pursuant to which they have agreed, e ffective as of the closing of the Company’s pending public stock offering, to transfer to the Company for cancellation the 10,000 shares of the Company’s Series A Preferred Stock that were previously issued to them.
 

 
Item 9.01      Exhibits
 
Exhibit No.
 
Description
10.01
 
Agreement dated November 22, 2010, between ONE Bio, Corp. and Michael S. Weingarten and ONE-V Group, LLC. (1)
     
     
(1)  Incorporated by reference to Exhibit 10.83 to Amendment #12 to the Company’s registration statement on Form S-1 filed on November 22, 2010.


SIGNATURES
 
Pursuant to the requirements of the Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ONE BIO, CORP.  
       
       
DATE: November 23 , 2010
By:
/s/ Marius Silvasan
 
   
Marius Silvasan
 
   
Chief Executive Officer
 
       
DATE: November 23 , 2010
By:
/s/ Cris Neely
 
   
Cris Neely
 
   
Chief Financial Officer and Director
 
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more One Bio (CE) Charts.
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more One Bio (CE) Charts.